These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37081303)

  • 1. Assessment of Escherichia coli-derived Recombinant Human Bone Morphogenic Protein-2 on Fertilization and Early Embryonic Development in Rats.
    Kim NH; Min SK; Lee MW; Kang SH
    Pharm Res; 2023 Jun; 40(6):1569-1576. PubMed ID: 37081303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The short-term effects of repetitive E. coli-derived rhBMP-2 administration through intravenous injection in rats.
    Lee JH; Lee EN; Nam SH
    Drug Chem Toxicol; 2014 Jan; 37(1):40-7. PubMed ID: 23841455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Intravenous Injection Toxicity Study of Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Rat.
    Lee JH; Lee EN; Chang BS; Lee CK
    Asian Spine J; 2014 Apr; 8(2):113-8. PubMed ID: 24761191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of Chinese hamster ovary cell versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model.
    Lee J; Lee EN; Yoon J; Chung SM; Prasad H; Susin C; Wikesjö UM
    J Periodontol; 2013 Mar; 84(3):415-22. PubMed ID: 22612368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.
    Im SK; Lee JH; Lee KY; Yoo SJ
    Orthop Surg; 2022 Jul; 14(7):1350-1358. PubMed ID: 35633034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2.
    Kim IS; Lee EN; Cho TH; Song YM; Hwang SJ; Oh JH; Park EK; Koo TY; Seo YK
    Tissue Eng Part A; 2011 Feb; 17(3-4):337-48. PubMed ID: 20868206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the effects of recombinant human bone morphogenetic protein-2 on pain-associated behaviors in a rat model following implantation near the sciatic nerve.
    Zanella JM; Waleh N; Orduña J; Montenegro J; Paulin J; McKay WF; Wilsey J
    J Neurosurg Spine; 2016 Aug; 25(2):154-64. PubMed ID: 26989976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: an experimental study in rat mandibular defects.
    Kimura M; Zhao M; Zellin G; Linde A
    Scand J Plast Reconstr Surg Hand Surg; 2000 Dec; 34(4):289-99. PubMed ID: 11195865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.
    Chung MK; Han SS; Kim JC
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):273-81. PubMed ID: 16814440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
    Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
    Yang JH; Kim HJ; Kim SE; Yun YP; Bae JH; Kim SJ; Choi KH; Song HR
    Cytotherapy; 2012 Mar; 14(3):315-26. PubMed ID: 22122301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of recombinant human BMP-6 in Escherichia coli and its purification and bioassay in vitro].
    Yang JH; Zhao L; Yang S; Wu SQ; Zhang J; Zhu TH
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):556-60. PubMed ID: 15969083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2.
    Bessho K; Konishi Y; Kaihara S; Fujimura K; Okubo Y; Iizuka T
    Br J Oral Maxillofac Surg; 2000 Dec; 38(6):645-649. PubMed ID: 11092786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of effects of rhBMP-2 on interbody fusion with a novel rat model.
    Okada R; Kaito T; Ishiguro H; Kushioka J; Otsuru S; Kanayama S; Bal Z; Kitaguchi K; Hashimoto K; Makino T; Takenaka S; Sakai Y; Yoshikawa H
    Spine J; 2020 May; 20(5):821-829. PubMed ID: 31901554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.
    Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Hasegawa-Nakamura K; Fujioka-Kobayashi M; Noguchi K
    Clin Oral Investig; 2017 Dec; 21(9):2671-2679. PubMed ID: 28197731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.